Gallagher Benefit Services’s AbbVie ABBV Stock Holding History

Gallagher Benefit Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$336K	Buy	+2,076	New	+$318K	0.07%	131

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Gallagher Benefit Services's ABBV Position: Q4 2022 in Review

Gallagher Benefit Services opened a new position in AbbVie (ABBV) in Q4 2022: 2,076 shares worth $336K. The stake represents 0.07% of the portfolio and ranks #131 among its holdings.

3,171 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

Gallagher Benefit Services held 2,076 shares of AbbVie worth $336K as of Q4 2022.
AbbVie was a new Gallagher Benefit Services position in Q4 2022.
AbbVie made up 0.07% of Gallagher Benefit Services's portfolio in Q4 2022, its #131 holding.
3,171 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Gallagher Benefit Services's 13F filing for Q4 2022, filed 27 Feb 2023.